Loading...

Sourcebio International Plc

SBI.LLSE
Healthcare
Medical - Diagnostics & Research
£115.00
£5.00(4.55%)

Sourcebio International Plc (SBI.L) Stock Overview

Explore Sourcebio International Plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap0
P/E Ratio5103.83
EPS (TTM)N/A
ROE0.42%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

SBI.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sourcebio International Plc (SBI.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5103.83 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;